New guidelines recommend starting cholesterol drugs in 30s for high-risk patients

One woman with familial hypercholesterolemia experienced cardiac arrest at age 34 due to delayed statin treatment, nearly fatal but survived after emergency intervention.

For decades, medicine has measured the heart's future in ten-year windows — a horizon too narrow to see the slow accumulation of damage that begins in youth. A coalition of eleven major medical organizations has now widened that view to thirty years, recommending that adults as young as thirty with elevated cholesterol or inherited risk begin statin therapy before middle age arrives with its consequences already written in arterial plaque. The change reflects a maturing understanding that cardiovascular disease is not a sudden event but a long conversation between biology and time — and that t

New guidelines recommend starting cholesterol drugs in 30s for high-risk patients

Cobertura Relacionada

Receba o Register no seu e-mail